Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: A brief report

European Journal of Haematology

Volumn 72, Issue 3, 2004, Pages 213-216

  Ahmed, Shahid ^a   Siddiqui, Anita K ^b   Iqbal, Uzma ^c   Sison, Cristina P ^d   Shahid, Rabia K ^e   Sheth, Manish ^c   Patel, Dilip V ^c   Russo, Linda A ^c  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^d Biostatistic Unit ^*  (United States)

^e DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

D dimer level; Low dose warfarin; Sickle cell disease; Vaso occlusive crisis

Indexed keywords

D DIMER; FIBRINOGEN; HEMOGLOBIN; HEMOGLOBIN F; HEMOGLOBIN S; HYDROXYUREA; WARFARIN;

ADULT; ANALYSIS OF VARIANCE; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; BLOOD TRANSFUSION; BLOOD VESSEL OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; THROMBOCYTE COUNT;

ADULT; ANALYSIS OF VARIANCE; ANEMIA, SICKLE CELL; ANTICOAGULANTS; BLOOD COAGULATION; CONSTRICTION, PATHOLOGIC; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; VASCULAR DISEASES; WARFARIN;

EID: 1342301507     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0902-4441.2003.00209.x     Document Type: Article

References (12)

1. EMBURY SH, HEBBEL RP, MOHANDAS N, et al. Sickle Cell Anemia: Basic Principles and Clinical Practice. New York: Raven Press, 1997.
2. FRANCIS RB, Jr, JOHNSON CS. Vascular occlusion in sickle cell disease: current concepts and unanswered questions. Blood 1991;77:1405-1414.
3. STUART MJ, SETTY BNY. Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology. Pediatr Pathol Mol Med 2001;20:27-46.
4. TOMER A, HARKER LA, KASEY S, et al. Thrombogenesis in sickle cell disease. J Lab Clin Med 2001;137:398-407.
5. SETTY BNY, RAO AK, STUART MJ. Thrombophilia in sickle cell disease. The red cell connection. Blood 2001;98:3228-3233.
6. KURANTSIN-MILLS J, OFOSU FA, SAFA TK, et al. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle-cell patients. Br J Haematol 1992;81:539-544.
7. PETER M, PLAAT BEC, TEN CATE H, et al. Enhanced thrombin generation in children with sickle cell disease. Thrombosis and Hemostasis 1994;71:169-172.
8. DEVINE DV, KINNEY TR, THOMAS PF, et al. Fragmant D-dimer levels: an objective marker of vaso-occlusive crisis and other complications of sickle cell disease. Blood 1986;68:317-19.
9. WOLTERS HJ, TEN CATE H, THOMAS LLM, et al. Low-intensity oral anticoagulation in sickle cell disease reverse the prethrombotic state. Promises for treatment? Br J Haematol 1995;90:715-717.
10. SCHNOG JB, KATER AP, MAC GILLAVRY MR, et al. Low adjusted-dose acenocumarol therapy in sickle cell disease: a pilot study. Am J Hematol 2001;68:179-183.
11. ELMS MJ, BUNCE IH, BUNDESEN PG, et al. Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody-coated latex particles. Am J Clin Pathol 1986;85:360-364.
12. ANDERSON DR, WELLS PS. D-dimer for the diagnosis of venous thromboembolism. Curr Opin Hematol 2000;7:296-301.